(Q36680064)

15 August 2017

1 reference

title

Mass spectrometry: uncovering the cancer proteome for diagnostics (English)

1 reference

15 August 2017

author

Eleftherios P. Diamandis

4

object named as

Eleftherios P Diamandis

1 reference

15 August 2017

author name string

Da-Elene van der Merwe

1

1 reference

15 August 2017

Katerina Oikonomopoulou

2

1 reference

15 August 2017

John Marshall

3

1 reference

15 August 2017

publication date

1 January 2007

1 reference

Advances in Cancer Research

15 August 2017

published in

1 reference

15 August 2017

volume

96

1 reference

15 August 2017

page(s)

23-50

1 reference

Mass spectrometry in proteomics

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Mass spectrometry-based proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The human plasma proteome: history, character, and diagnostic prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The human plasma proteome: a nonredundant list developed by combination of four separate sources

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Signal in Noise: Evaluating Reported Reproducibility of Serum Proteomic Tests for Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Diagnostic potential of serum proteomic patterns in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

New tools for quantitative phosphoproteome analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

High-resolution serum proteomic features for ovarian cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Analysis of Mass Spectrometry Profiles of the Serum Proteome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Laser capture microdissection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The case for early detection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Electrospray ionization for mass spectrometry of large biomolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Protein profiles in sera of patients with malignant cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Quantitative analysis of complex protein mixtures using isotope-coded affinity tags

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Classifying human cancer by analysis of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Serial analysis of gene expression and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The Cancer Genome Anatomy Project: Power Tools for Cancer Biologists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Tandem quadrupole Fourier-transform mass spectrometry of oligopeptides and small proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Screening for ovarian cancer: a pilot randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Classification of human cancer cells by means of capillary gas chromatography and pattern recognition analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Putative protein markers in the sera of men with prostatic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomics in pathology research.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Molecular profiling of human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The microenvironment of the tumour-host interface

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Clinical proteomics: Written in blood

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Importance of communication between producers and consumers of publicly available experimental data

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Towards evidence-based use of serum tumour marker requests: an audit of use in a tertiary hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Probability-based validation of protein identifications using a modified SEQUEST algorithm

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Analysis of proteins and proteomes by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Recent developments in ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Quantitation of peptides and proteins by matrix-assisted laser desorption/ionization mass spectrometry using (18)O-labeled internal standards

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Laser desorption time-of-flight mass spectrometric analysis of transferrin precipitated with antiserum: a unique simple method to identify molecular weight variants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Evidence-based guidelines in laboratory medicine: principles and methods

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomics to study genes and genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

A common open representation of mass spectrometry data and its application to proteomics research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Use of proteomic patterns in serum to identify ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Serum proteomic patterns for detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Clinical proteomics: translating benchside promise into bedside reality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Gene discovery using the serial analysis of gene expression technique: implications for cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomics delivers on promise of cancer biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Mass spectrometry-based clinical proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Cancer. Developing molecular biomarkers for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Rules of evidence for cancer molecular-marker discovery and validation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Lessons from controversy: ovarian cancer screening and serum proteomics.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

An accurate mass tag strategy for quantitative and high-throughput proteome measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

A data review and re-assessment of ovarian cancer serum proteomic profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Early detection cancer research network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Tumor markers in the laboratory: closing the guideline-practice gap

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Phases of biomarker development for early detection of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Expression profiling of breast cancer cells by differential peptide display

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Serial analysis of gene expression (SAGE): unraveling the bioinformatics tools

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

From genomics to proteomics

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Quality control and standardization of tumour marker tests

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Tissue-specific microdissection coupled with ProteinChip array technologies: applications in cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The application of new software tools to quantitative protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry: I. Statistically annotated datasets for peptide sequences and proteins identified via the application of ICAT

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

The application of new software tools to quantitative protein profiling via isotope-coded affinity tag (ICAT) and tandem mass spectrometry: II. Evaluation of tandem mass spectrometry methodologies for large-scale protein analysis, and the applicatio

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Identification of patients with head and neck cancer using serum protein profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Recent trends in protein biochip technology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Multiple parameter cross-species protein identification using MultiIdent--a world-wide web accessible tool.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteinchip(R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteomic patterns of tumour subsets in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Proteolytic 18O labeling for comparative proteomics: model studies with two serotypes of adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Arrays of arrays for high-throughput gene expression profiling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

ProFound: an expert system for protein identification using mass spectrometric peptide mapping information

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2806%2996002-3

7 January 2021

10.1016/S0065-230X(06)96002-3

Identifiers

DOI

1 reference

15 August 2017

1 reference